Cargando…
Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies
BACKGROUND: Diabetes is a common disease marked by high blood sugars. An earlier clinical trial in type 1 diabetic subjects (T1Ds) found that repeat BCG vaccinations succeeded in lowering HbA1c values over a multi-year course. Here we seek to determine whether BCG therapy for bladder cancer may impr...
Autores principales: | Dias, Hans F., Mochizuki, Yoshihiko, Kühtreiber, Willem M., Takahashi, Hiroyuki, Zheng, Hui, Faustman, Denise L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858877/ https://www.ncbi.nlm.nih.gov/pubmed/36662841 http://dx.doi.org/10.1371/journal.pone.0276423 |
Ejemplares similares
-
Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy
por: Klebanov, Nikolai, et al.
Publicado: (2018) -
Tuberculous Spondylitis after Intrarenal Bacille Calmette-Guerin (BCG) Therapy
por: Kajihara, Yusaku, et al.
Publicado: (2019) -
The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines
por: Villanueva, Paola, et al.
Publicado: (2022) -
Guillain Barré syndrome associated with bladder instillation of Bacille Calmette Guérin (BCG)
por: Webb, Karmel, et al.
Publicado: (2018) -
Mycobacterium bovis Osteitis Following Immunization with Bacille Calmette-Guérin (BCG) in Korea
por: Choi, Youn Young, et al.
Publicado: (2018)